This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Charles Marwick

JAMA. 1998;280:313.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE ACCELERATING PACE of new vaccine development has made incorporating these agents into the childhood immunization schedule a major challenge. In 1989, it took 8 injections to immunize children from birth to 16 years of age; in 1998, the number has nearly doubled: 14 injections are required.

Nor is the pace slackening. In the next few years, vaccines to prevent infection with Streptococcus pneumoniae, Neisseria meningitidis in infants, respiratory syncytial virus, and Lyme disease (JAMA. 1998;279:1937-1938) are likely to be licensed.

Patients—and Clinicians—Unhappy

"Sometimes 3 or even 4 injections are indicated for a single visit," said Bruce G. Weniger, MD, assistant chief for vaccine development in the National Immunization Program at the Centers for Disease Control and Prevention (CDC), Atlanta, Ga, speaking last month at the first Conference on Vaccine Research. The conference was sponsored by the National Foundation for Infectious Diseases, CDC, National Institute . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?